The CMT4C Advocacy Group is working to connect those affected by Charcot-Marie-Tooth disease type 4C: patients, loved ones and the organizations and researchers who are developing treatments.
CMT4C is a rare disease caused by a mutation of a gene called SH3TC2 which affects the peripheral nerves and results in progressive loss of function and sensation in the extremities, along with deformities in the spine and feet.
While there is currently no FDA approved treatments or cures for any form of CMT, there is lots of promising research on the horizon.
Our purpose is to create a community that embraces individuals impacted by CMT4C, along with their families and the professionals dedicated to supporting us, as we collectively strive towards a cure.